Grace Therapeutics GRCE Ratios (2011-2026)

NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST
Reported Financials

Grace Therapeutics Quarterly Ratios

Periods 62 quarters
Latest Sep 2026

Grace Therapeutics ratios data for the quarter ended Sep 2026. These financial ratios cover 62 quarters of results from May 2011 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios May2011 Aug2011 Nov2011 Feb2012 May2012 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Nov2013 Feb2014 May2014 Aug2014 Nov2014 Feb2015 May2015 Aug2015 Nov2015 Feb2016 May2016 Aug2016 Nov2016 Feb2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Profitability
Gross Margin
EBT Margin
-1,421.70%-2,353.85%-3,748.03%-207.61%-1,648.04%-545.35%-1,345.93%-2,085.51%-11,198.58%
EBIT Margin
-2,111.91%-2,654.40%-2,916.54%-1,729.89%-1,514.71%-1,470.35%-1,423.84%-2,181.16%-11,288.65%
EBITDA Margin
-2,111.49%-2,653.30%-2,914.96%-1,728.80%-1,513.73%-1,470.35%-1,422.09%-2,179.71%-11,287.23%
Operating Margin
-2,111.91%-2,654.40%-2,916.54%-1,729.89%-1,514.71%-1,470.35%-1,423.84%-2,181.16%-11,288.65%
Net Margin
-1,113.62%-1,885.71%-3,271.65%345.65%-1,648.04%-545.35%-1,345.93%-853.62%-11,198.58%
FCF Margin
-1,530.21%-2,329.12%-3,240.16%-1,605.43%-882.84%-1,827.33%-1,296.51%-1,228.26%-2,284.40%
Efficiency
Inventory AverageInventory Avg.
Assets AverageAssets Avg.
117.01M121.42M126.78M122.92M118.86M97.96M76.08M75.62M77.20M74.74M71.51M67.53M63.29M66.61M70.90M68.19M67.53M67.57M58.36M53.89M
Equity AverageEquity Avg.
112.63M109.67M106.34M102.28M98.44M82.34M65.98M65.38M65.71M63.21M60.55M57.75M54.14M59.37M65.08M63.18M63.85M64.39M56.05M51.85M
Invested CapitalInvested Cap.
68.03M64.70M
Asset Utilization RatioAsset Util.
0.010.000.000.010.010.010.010.010.010.010.01
Leverage & Solvency
Interest Coverage RatioInterest Cover
Debt Ratio
0.000.00
Times Interest Earned
Valuation
Price to EarningsP/E
Price to SalesP/S
40.85229.3384.6072.9569.7142.9658.9361.2973.14108.1559.30
Price to BookP/B
0.500.420.370.260.230.300.370.310.420.520.500.540.730.470.650.670.831.160.770.78
Enterprise Value
9.48M1.29M-0.13M-9.06M-8.95M-7.37M2.00M-6.01M2.05M9.23M10.20M15.25M26.87M9.14M39.15M25.24M34.87M57.21M23.19M21.94M
EV to EBITDA
Market Capitalization
55.80M44.95M38.27M25.88M22.31M20.52M23.64M21.00M27.16M32.24M29.61M30.42M37.92M31.28M41.07M42.10M53.54M74.19M36.94M43.25M
Return Ratios
Return on Sales [ROS]ROS
-987.12%-7,953.57%-2,111.91%-2,654.40%-2,916.54%-1,729.89%-1,514.71%-1,470.35%-1,423.84%-2,181.16%-11,288.65%
Return on Capital Employed [ROCE]ROCE
-11.82%-13.19%-13.95%-15.71%-16.02%-55.16%-70.00%-65.83%-63.19%-17.59%-19.39%-24.82%-27.34%-25.79%-21.59%-18.68%-16.98%-16.93%-41.86%-45.28%
Return on Assets [ROA]ROA
-9.88%-8.09%-8.85%-13.94%-14.51%-43.31%-55.11%-53.25%-50.23%-17.20%-16.01%-17.19%-21.13%-14.36%-14.55%-11.47%-8.85%-11.53%-34.65%-39.74%
Return on Equity [ROE]ROE
-10.26%-8.95%-10.56%-16.75%-17.52%-51.53%-63.54%-61.60%-59.01%-20.33%-18.90%-20.10%-24.70%-16.11%-15.85%-12.37%-9.36%-12.10%-36.07%-41.30%

Grace Therapeutics Ratios API

Pull Grace Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=GRCE&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY